Related Experiment Video
Updated: Jun 8, 2026

Mouse Model of Acute to Chronic Kidney Disease Transition Induced by Renal Ischemia/Reperfusion Injury
Published on: February 10, 2026
Metformin-related lactic acidosis in patients with acute kidney injury
Vassilios Devetzis1, Ploumis Passadakis, Stelios Panagoutsos
1Division of Nephrology, University Hospital of Alexandroupolis, Faculty of Medicine, Democritus University of Thrace, Dragana, 68100 Alexandroupolis, Greece. vasdeve@yahoo.gr
Background:
Metformin is nowadays considered as first-line therapy in individuals with non-insulin dependent diabetes mellitus (NIDDM). Metformin-related lactic acidosis (MALA) occurs more frequently after inappropriate use especially in patients with acute kidney injury (AKI) or chronic kidney disease (CKD). Thus, its prescription in these patients is contraindicated, while the role of dialysis is under evaluation.
Methods:
We describe two cases of severe metformin-related lactic acidosis with underlying acute kidney injury, which were treated with dialysis.
Results:
In both cases, lactic acidosis occurred on a background of acute decline in renal function, possibly due to drug accumulation. It is interesting that metformin was contraindicated in one case.
Conclusion:
Lactic acidosis is a rare but potentially fatal adverse effect of metformin, particularly in patients with AKI, which should always be considered in clinical practice. Dialysis seems to contribute significantly to the management of this life-threatening condition and the improvement in outcome.
Related Concept Videos
Acute Kidney Injury I: Introduction
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury II: Pathophysiology
Diabetic Ketoacidosis l: Introduction